nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—Feeling abnormal—Acitretin—psoriasis	0.00279	0.0029	CcSEcCtD
Apomorphine—Pneumonia—Mycophenolate mofetil—psoriasis	0.00277	0.00288	CcSEcCtD
Apomorphine—Mental disorder—Mycophenolic acid—psoriasis	0.00275	0.00285	CcSEcCtD
Apomorphine—Urinary tract infection—Cyclosporine—psoriasis	0.00275	0.00285	CcSEcCtD
Apomorphine—Sweating increased—Hydrocortisone—psoriasis	0.00274	0.00285	CcSEcCtD
Apomorphine—Asthenia—Calcitriol—psoriasis	0.00273	0.00284	CcSEcCtD
Apomorphine—Psychotic disorder—Dexamethasone—psoriasis	0.00272	0.00282	CcSEcCtD
Apomorphine—Psychotic disorder—Betamethasone—psoriasis	0.00272	0.00282	CcSEcCtD
Apomorphine—Pruritus—Calcitriol—psoriasis	0.00269	0.0028	CcSEcCtD
Apomorphine—Urinary tract infection—Mycophenolate mofetil—psoriasis	0.00268	0.00278	CcSEcCtD
Apomorphine—Headache—Methoxsalen—psoriasis	0.00268	0.00278	CcSEcCtD
Apomorphine—Cardiac failure congestive—Prednisone—psoriasis	0.00267	0.00277	CcSEcCtD
Apomorphine—Oedema—Hydroxyurea—psoriasis	0.00266	0.00276	CcSEcCtD
Apomorphine—Back pain—Mycophenolic acid—psoriasis	0.00264	0.00274	CcSEcCtD
Apomorphine—Diarrhoea—Calcitriol—psoriasis	0.00261	0.0027	CcSEcCtD
Apomorphine—Sweating increased—Triamcinolone—psoriasis	0.00258	0.00268	CcSEcCtD
Apomorphine—Nausea—Methoxsalen—psoriasis	0.00254	0.00263	CcSEcCtD
Apomorphine—Ecchymosis—Methotrexate—psoriasis	0.00252	0.00262	CcSEcCtD
Apomorphine—Hallucination—Mycophenolate mofetil—psoriasis	0.00246	0.00256	CcSEcCtD
Apomorphine—Syncope—Mycophenolic acid—psoriasis	0.00245	0.00254	CcSEcCtD
Apomorphine—Asthenia—Acitretin—psoriasis	0.00243	0.00252	CcSEcCtD
Apomorphine—Vomiting—Calcitriol—psoriasis	0.00242	0.00251	CcSEcCtD
Apomorphine—Loss of consciousness—Mycophenolic acid—psoriasis	0.0024	0.00249	CcSEcCtD
Apomorphine—Pruritus—Acitretin—psoriasis	0.0024	0.00249	CcSEcCtD
Apomorphine—Pruritus—Fluocinolone Acetonide—psoriasis	0.00239	0.00248	CcSEcCtD
Apomorphine—Headache—Calcitriol—psoriasis	0.00239	0.00248	CcSEcCtD
Apomorphine—Dyspnoea—Hydroxyurea—psoriasis	0.00237	0.00246	CcSEcCtD
Apomorphine—Psychotic disorder—Prednisone—psoriasis	0.00237	0.00246	CcSEcCtD
Apomorphine—Somnolence—Hydroxyurea—psoriasis	0.00237	0.00245	CcSEcCtD
Apomorphine—Flushing—Cyclosporine—psoriasis	0.00235	0.00244	CcSEcCtD
Apomorphine—Sweating increased—Betamethasone—psoriasis	0.00234	0.00243	CcSEcCtD
Apomorphine—Sweating increased—Dexamethasone—psoriasis	0.00234	0.00243	CcSEcCtD
Apomorphine—Arthralgia—Mycophenolic acid—psoriasis	0.00232	0.00241	CcSEcCtD
Apomorphine—Chest pain—Mycophenolic acid—psoriasis	0.00232	0.00241	CcSEcCtD
Apomorphine—Diarrhoea—Acitretin—psoriasis	0.00232	0.00241	CcSEcCtD
Apomorphine—Anxiety—Mycophenolic acid—psoriasis	0.00232	0.0024	CcSEcCtD
Apomorphine—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.00231	0.0024	CcSEcCtD
Apomorphine—Fatigue—Hydroxyurea—psoriasis	0.00229	0.00238	CcSEcCtD
Apomorphine—Constipation—Hydroxyurea—psoriasis	0.00227	0.00236	CcSEcCtD
Apomorphine—Nausea—Calcitriol—psoriasis	0.00226	0.00235	CcSEcCtD
Apomorphine—Confusional state—Mycophenolic acid—psoriasis	0.00225	0.00233	CcSEcCtD
Apomorphine—Hallucination—Hydrocortisone—psoriasis	0.00224	0.00233	CcSEcCtD
Apomorphine—Dizziness—Acitretin—psoriasis	0.00224	0.00232	CcSEcCtD
Apomorphine—Dizziness—Fluocinolone Acetonide—psoriasis	0.00223	0.00232	CcSEcCtD
Apomorphine—Oedema—Mycophenolic acid—psoriasis	0.00223	0.00231	CcSEcCtD
Apomorphine—Mental disorder—Cyclosporine—psoriasis	0.00222	0.00231	CcSEcCtD
Apomorphine—Feeling abnormal—Hydroxyurea—psoriasis	0.00219	0.00227	CcSEcCtD
Apomorphine—Shock—Mycophenolic acid—psoriasis	0.00219	0.00227	CcSEcCtD
Apomorphine—Mental disorder—Mycophenolate mofetil—psoriasis	0.00217	0.00225	CcSEcCtD
Apomorphine—Vomiting—Acitretin—psoriasis	0.00215	0.00224	CcSEcCtD
Apomorphine—Hyperhidrosis—Mycophenolic acid—psoriasis	0.00215	0.00223	CcSEcCtD
Apomorphine—Vomiting—Fluocinolone Acetonide—psoriasis	0.00215	0.00223	CcSEcCtD
Apomorphine—Headache—Acitretin—psoriasis	0.00212	0.0022	CcSEcCtD
Apomorphine—Headache—Fluocinolone Acetonide—psoriasis	0.00212	0.0022	CcSEcCtD
Apomorphine—Back pain—Mycophenolate mofetil—psoriasis	0.00208	0.00216	CcSEcCtD
Apomorphine—Hypotension—Mycophenolic acid—psoriasis	0.00208	0.00216	CcSEcCtD
Apomorphine—Sweating increased—Prednisone—psoriasis	0.00204	0.00212	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.00203	0.00211	CcSEcCtD
Apomorphine—Insomnia—Mycophenolic acid—psoriasis	0.00202	0.00209	CcSEcCtD
Apomorphine—Nausea—Acitretin—psoriasis	0.00201	0.00209	CcSEcCtD
Apomorphine—Nausea—Fluocinolone Acetonide—psoriasis	0.00201	0.00208	CcSEcCtD
Apomorphine—Dyspnoea—Mycophenolic acid—psoriasis	0.00199	0.00206	CcSEcCtD
Apomorphine—Somnolence—Mycophenolic acid—psoriasis	0.00198	0.00206	CcSEcCtD
Apomorphine—Mental disorder—Hydrocortisone—psoriasis	0.00198	0.00205	CcSEcCtD
Apomorphine—Syncope—Mycophenolate mofetil—psoriasis	0.00193	0.002	CcSEcCtD
Apomorphine—Fatigue—Mycophenolic acid—psoriasis	0.00192	0.00199	CcSEcCtD
Apomorphine—Hallucination—Dexamethasone—psoriasis	0.00192	0.00199	CcSEcCtD
Apomorphine—Hallucination—Betamethasone—psoriasis	0.00192	0.00199	CcSEcCtD
Apomorphine—Asthenia—Hydroxyurea—psoriasis	0.00191	0.00198	CcSEcCtD
Apomorphine—Constipation—Mycophenolic acid—psoriasis	0.00191	0.00198	CcSEcCtD
Apomorphine—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.00189	0.00196	CcSEcCtD
Apomorphine—Arthralgia—Cyclosporine—psoriasis	0.00188	0.00195	CcSEcCtD
Apomorphine—Chest pain—Cyclosporine—psoriasis	0.00188	0.00195	CcSEcCtD
Apomorphine—Anxiety—Cyclosporine—psoriasis	0.00187	0.00194	CcSEcCtD
Apomorphine—Feeling abnormal—Mycophenolic acid—psoriasis	0.00184	0.00191	CcSEcCtD
Apomorphine—Chest pain—Mycophenolate mofetil—psoriasis	0.00183	0.0019	CcSEcCtD
Apomorphine—Arthralgia—Mycophenolate mofetil—psoriasis	0.00183	0.0019	CcSEcCtD
Apomorphine—Anxiety—Mycophenolate mofetil—psoriasis	0.00183	0.0019	CcSEcCtD
Apomorphine—Diarrhoea—Hydroxyurea—psoriasis	0.00182	0.00189	CcSEcCtD
Apomorphine—Confusional state—Cyclosporine—psoriasis	0.00182	0.00189	CcSEcCtD
Apomorphine—Oedema—Cyclosporine—psoriasis	0.0018	0.00187	CcSEcCtD
Apomorphine—Syncope—Prednisolone—psoriasis	0.0018	0.00187	CcSEcCtD
Apomorphine—Back pain—Triamcinolone—psoriasis	0.00179	0.00185	CcSEcCtD
Apomorphine—Confusional state—Mycophenolate mofetil—psoriasis	0.00177	0.00184	CcSEcCtD
Apomorphine—Loss of consciousness—Prednisolone—psoriasis	0.00177	0.00183	CcSEcCtD
Apomorphine—Syncope—Hydrocortisone—psoriasis	0.00176	0.00183	CcSEcCtD
Apomorphine—Dizziness—Hydroxyurea—psoriasis	0.00176	0.00183	CcSEcCtD
Apomorphine—Oedema—Mycophenolate mofetil—psoriasis	0.00176	0.00182	CcSEcCtD
Apomorphine—Hyperhidrosis—Cyclosporine—psoriasis	0.00174	0.00181	CcSEcCtD
Apomorphine—Shock—Mycophenolate mofetil—psoriasis	0.00173	0.0018	CcSEcCtD
Apomorphine—Loss of consciousness—Hydrocortisone—psoriasis	0.00173	0.00179	CcSEcCtD
Apomorphine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.0017	0.00176	CcSEcCtD
Apomorphine—Vomiting—Hydroxyurea—psoriasis	0.00169	0.00176	CcSEcCtD
Apomorphine—Hallucination—Prednisone—psoriasis	0.00167	0.00173	CcSEcCtD
Apomorphine—Headache—Hydroxyurea—psoriasis	0.00167	0.00173	CcSEcCtD
Apomorphine—Anxiety—Hydrocortisone—psoriasis	0.00167	0.00173	CcSEcCtD
Apomorphine—Syncope—Triamcinolone—psoriasis	0.00166	0.00172	CcSEcCtD
Apomorphine—Hypotension—Mycophenolate mofetil—psoriasis	0.00164	0.0017	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.00164	0.0017	CcSEcCtD
Apomorphine—Oedema—Prednisolone—psoriasis	0.00164	0.0017	CcSEcCtD
Apomorphine—Insomnia—Cyclosporine—psoriasis	0.00163	0.00169	CcSEcCtD
Apomorphine—Loss of consciousness—Triamcinolone—psoriasis	0.00162	0.00169	CcSEcCtD
Apomorphine—Shock—Prednisolone—psoriasis	0.00161	0.00167	CcSEcCtD
Apomorphine—Dyspnoea—Cyclosporine—psoriasis	0.00161	0.00167	CcSEcCtD
Apomorphine—Somnolence—Cyclosporine—psoriasis	0.0016	0.00166	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.0016	0.00166	CcSEcCtD
Apomorphine—Oedema—Hydrocortisone—psoriasis	0.0016	0.00166	CcSEcCtD
Apomorphine—Asthenia—Mycophenolic acid—psoriasis	0.0016	0.00166	CcSEcCtD
Apomorphine—Insomnia—Mycophenolate mofetil—psoriasis	0.00159	0.00165	CcSEcCtD
Apomorphine—Hyperhidrosis—Prednisolone—psoriasis	0.00159	0.00165	CcSEcCtD
Apomorphine—Nausea—Hydroxyurea—psoriasis	0.00158	0.00164	CcSEcCtD
Apomorphine—Pruritus—Mycophenolic acid—psoriasis	0.00158	0.00164	CcSEcCtD
Apomorphine—Shock—Hydrocortisone—psoriasis	0.00158	0.00164	CcSEcCtD
Apomorphine—Pneumonia—Methotrexate—psoriasis	0.00157	0.00163	CcSEcCtD
Apomorphine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00157	0.00163	CcSEcCtD
Apomorphine—Somnolence—Mycophenolate mofetil—psoriasis	0.00156	0.00162	CcSEcCtD
Apomorphine—Drowsiness—Methotrexate—psoriasis	0.00156	0.00162	CcSEcCtD
Apomorphine—Flushing—Prednisone—psoriasis	0.00156	0.00162	CcSEcCtD
Apomorphine—Fatigue—Cyclosporine—psoriasis	0.00155	0.00161	CcSEcCtD
Apomorphine—Hyperhidrosis—Hydrocortisone—psoriasis	0.00155	0.00161	CcSEcCtD
Apomorphine—Constipation—Cyclosporine—psoriasis	0.00154	0.0016	CcSEcCtD
Apomorphine—Diarrhoea—Mycophenolic acid—psoriasis	0.00152	0.00158	CcSEcCtD
Apomorphine—Oedema—Triamcinolone—psoriasis	0.00151	0.00157	CcSEcCtD
Apomorphine—Syncope—Dexamethasone—psoriasis	0.0015	0.00156	CcSEcCtD
Apomorphine—Syncope—Betamethasone—psoriasis	0.0015	0.00156	CcSEcCtD
Apomorphine—Constipation—Mycophenolate mofetil—psoriasis	0.0015	0.00156	CcSEcCtD
Apomorphine—Hypotension—Hydrocortisone—psoriasis	0.0015	0.00155	CcSEcCtD
Apomorphine—Feeling abnormal—Cyclosporine—psoriasis	0.00149	0.00154	CcSEcCtD
Apomorphine—Shock—Triamcinolone—psoriasis	0.00148	0.00154	CcSEcCtD
Apomorphine—Insomnia—Prednisolone—psoriasis	0.00148	0.00154	CcSEcCtD
Apomorphine—Loss of consciousness—Dexamethasone—psoriasis	0.00147	0.00153	CcSEcCtD
Apomorphine—Loss of consciousness—Betamethasone—psoriasis	0.00147	0.00153	CcSEcCtD
Apomorphine—Dizziness—Mycophenolic acid—psoriasis	0.00147	0.00153	CcSEcCtD
Apomorphine—Mental disorder—Prednisone—psoriasis	0.00147	0.00153	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00146	0.00151	CcSEcCtD
Apomorphine—Hyperhidrosis—Triamcinolone—psoriasis	0.00146	0.00151	CcSEcCtD
Apomorphine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.00145	0.0015	CcSEcCtD
Apomorphine—Insomnia—Hydrocortisone—psoriasis	0.00145	0.0015	CcSEcCtD
Apomorphine—Anxiety—Dexamethasone—psoriasis	0.00142	0.00148	CcSEcCtD
Apomorphine—Anxiety—Betamethasone—psoriasis	0.00142	0.00148	CcSEcCtD
Apomorphine—Vomiting—Mycophenolic acid—psoriasis	0.00142	0.00147	CcSEcCtD
Apomorphine—Headache—Mycophenolic acid—psoriasis	0.0014	0.00145	CcSEcCtD
Apomorphine—Fatigue—Hydrocortisone—psoriasis	0.00138	0.00143	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.00137	0.00143	CcSEcCtD
Apomorphine—Oedema—Dexamethasone—psoriasis	0.00137	0.00142	CcSEcCtD
Apomorphine—Oedema—Betamethasone—psoriasis	0.00137	0.00142	CcSEcCtD
Apomorphine—Insomnia—Triamcinolone—psoriasis	0.00136	0.00142	CcSEcCtD
Apomorphine—Feeling abnormal—Prednisolone—psoriasis	0.00135	0.0014	CcSEcCtD
Apomorphine—Shock—Dexamethasone—psoriasis	0.00135	0.0014	CcSEcCtD
Apomorphine—Shock—Betamethasone—psoriasis	0.00135	0.0014	CcSEcCtD
Apomorphine—Dyspnoea—Triamcinolone—psoriasis	0.00134	0.0014	CcSEcCtD
Apomorphine—Nausea—Mycophenolic acid—psoriasis	0.00132	0.00137	CcSEcCtD
Apomorphine—Hyperhidrosis—Betamethasone—psoriasis	0.00132	0.00137	CcSEcCtD
Apomorphine—Hyperhidrosis—Dexamethasone—psoriasis	0.00132	0.00137	CcSEcCtD
Apomorphine—Feeling abnormal—Hydrocortisone—psoriasis	0.00132	0.00137	CcSEcCtD
Apomorphine—Syncope—Prednisone—psoriasis	0.00131	0.00136	CcSEcCtD
Apomorphine—Fatigue—Triamcinolone—psoriasis	0.0013	0.00135	CcSEcCtD
Apomorphine—Asthenia—Cyclosporine—psoriasis	0.00129	0.00134	CcSEcCtD
Apomorphine—Loss of consciousness—Prednisone—psoriasis	0.00128	0.00133	CcSEcCtD
Apomorphine—Hypotension—Dexamethasone—psoriasis	0.00128	0.00133	CcSEcCtD
Apomorphine—Hypotension—Betamethasone—psoriasis	0.00128	0.00133	CcSEcCtD
Apomorphine—Pruritus—Cyclosporine—psoriasis	0.00128	0.00132	CcSEcCtD
Apomorphine—Asthenia—Mycophenolate mofetil—psoriasis	0.00126	0.00131	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.00125	0.00129	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.00125	0.00129	CcSEcCtD
Apomorphine—Pruritus—Mycophenolate mofetil—psoriasis	0.00124	0.00129	CcSEcCtD
Apomorphine—Arthralgia—Prednisone—psoriasis	0.00124	0.00129	CcSEcCtD
Apomorphine—Feeling abnormal—Triamcinolone—psoriasis	0.00124	0.00129	CcSEcCtD
Apomorphine—Anxiety—Prednisone—psoriasis	0.00124	0.00129	CcSEcCtD
Apomorphine—Insomnia—Betamethasone—psoriasis	0.00124	0.00128	CcSEcCtD
Apomorphine—Insomnia—Dexamethasone—psoriasis	0.00124	0.00128	CcSEcCtD
Apomorphine—Diarrhoea—Cyclosporine—psoriasis	0.00123	0.00128	CcSEcCtD
Apomorphine—Mental disorder—Methotrexate—psoriasis	0.00123	0.00127	CcSEcCtD
Apomorphine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.0012	0.00125	CcSEcCtD
Apomorphine—Dizziness—Cyclosporine—psoriasis	0.00119	0.00124	CcSEcCtD
Apomorphine—Oedema—Prednisone—psoriasis	0.00119	0.00124	CcSEcCtD
Apomorphine—Back pain—Methotrexate—psoriasis	0.00118	0.00123	CcSEcCtD
Apomorphine—Fatigue—Dexamethasone—psoriasis	0.00118	0.00122	CcSEcCtD
Apomorphine—Fatigue—Betamethasone—psoriasis	0.00118	0.00122	CcSEcCtD
Apomorphine—Shock—Prednisone—psoriasis	0.00117	0.00122	CcSEcCtD
Apomorphine—Dizziness—Mycophenolate mofetil—psoriasis	0.00116	0.00121	CcSEcCtD
Apomorphine—Hyperhidrosis—Prednisone—psoriasis	0.00115	0.0012	CcSEcCtD
Apomorphine—Asthenia—Hydrocortisone—psoriasis	0.00115	0.00119	CcSEcCtD
Apomorphine—Vomiting—Cyclosporine—psoriasis	0.00115	0.00119	CcSEcCtD
Apomorphine—Pruritus—Hydrocortisone—psoriasis	0.00113	0.00118	CcSEcCtD
Apomorphine—Headache—Cyclosporine—psoriasis	0.00113	0.00117	CcSEcCtD
Apomorphine—Feeling abnormal—Betamethasone—psoriasis	0.00113	0.00117	CcSEcCtD
Apomorphine—Feeling abnormal—Dexamethasone—psoriasis	0.00113	0.00117	CcSEcCtD
Apomorphine—Vomiting—Mycophenolate mofetil—psoriasis	0.00112	0.00116	CcSEcCtD
Apomorphine—Headache—Mycophenolate mofetil—psoriasis	0.0011	0.00114	CcSEcCtD
Apomorphine—Diarrhoea—Hydrocortisone—psoriasis	0.0011	0.00114	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Prednisone—psoriasis	0.00109	0.00113	CcSEcCtD
Apomorphine—Dizziness—Prednisolone—psoriasis	0.00108	0.00113	CcSEcCtD
Apomorphine—Asthenia—Triamcinolone—psoriasis	0.00108	0.00112	CcSEcCtD
Apomorphine—Insomnia—Prednisone—psoriasis	0.00108	0.00112	CcSEcCtD
Apomorphine—Nausea—Cyclosporine—psoriasis	0.00107	0.00111	CcSEcCtD
Apomorphine—Pruritus—Triamcinolone—psoriasis	0.00107	0.00111	CcSEcCtD
Apomorphine—Dizziness—Hydrocortisone—psoriasis	0.00106	0.0011	CcSEcCtD
Apomorphine—Nausea—Mycophenolate mofetil—psoriasis	0.00104	0.00108	CcSEcCtD
Apomorphine—Chest pain—Methotrexate—psoriasis	0.00104	0.00108	CcSEcCtD
Apomorphine—Arthralgia—Methotrexate—psoriasis	0.00104	0.00108	CcSEcCtD
Apomorphine—Fatigue—Prednisone—psoriasis	0.00103	0.00107	CcSEcCtD
Apomorphine—Headache—Prednisolone—psoriasis	0.00103	0.00107	CcSEcCtD
Apomorphine—Constipation—Prednisone—psoriasis	0.00102	0.00106	CcSEcCtD
Apomorphine—Vomiting—Hydrocortisone—psoriasis	0.00102	0.00106	CcSEcCtD
Apomorphine—Confusional state—Methotrexate—psoriasis	0.001	0.00104	CcSEcCtD
Apomorphine—Headache—Hydrocortisone—psoriasis	0.001	0.00104	CcSEcCtD
Apomorphine—Dizziness—Triamcinolone—psoriasis	0.000997	0.00103	CcSEcCtD
Apomorphine—Feeling abnormal—Prednisone—psoriasis	0.000982	0.00102	CcSEcCtD
Apomorphine—Asthenia—Betamethasone—psoriasis	0.000982	0.00102	CcSEcCtD
Apomorphine—Asthenia—Dexamethasone—psoriasis	0.000982	0.00102	CcSEcCtD
Apomorphine—Nausea—Prednisolone—psoriasis	0.000974	0.00101	CcSEcCtD
Apomorphine—Pruritus—Betamethasone—psoriasis	0.000968	0.001	CcSEcCtD
Apomorphine—Pruritus—Dexamethasone—psoriasis	0.000968	0.001	CcSEcCtD
Apomorphine—Hyperhidrosis—Methotrexate—psoriasis	0.000963	0.000999	CcSEcCtD
Apomorphine—Vomiting—Triamcinolone—psoriasis	0.000959	0.000995	CcSEcCtD
Apomorphine—Nausea—Hydrocortisone—psoriasis	0.000952	0.000987	CcSEcCtD
Apomorphine—Headache—Triamcinolone—psoriasis	0.000945	0.00098	CcSEcCtD
Apomorphine—Diarrhoea—Betamethasone—psoriasis	0.000936	0.000972	CcSEcCtD
Apomorphine—Diarrhoea—Dexamethasone—psoriasis	0.000936	0.000972	CcSEcCtD
Apomorphine—Hypotension—Methotrexate—psoriasis	0.000931	0.000966	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000908	0.000942	CcSEcCtD
Apomorphine—Dizziness—Dexamethasone—psoriasis	0.000905	0.000939	CcSEcCtD
Apomorphine—Dizziness—Betamethasone—psoriasis	0.000905	0.000939	CcSEcCtD
Apomorphine—Insomnia—Methotrexate—psoriasis	0.000901	0.000935	CcSEcCtD
Apomorphine—Nausea—Triamcinolone—psoriasis	0.000896	0.00093	CcSEcCtD
Apomorphine—Dyspnoea—Methotrexate—psoriasis	0.000888	0.000921	CcSEcCtD
Apomorphine—Somnolence—Methotrexate—psoriasis	0.000886	0.000919	CcSEcCtD
Apomorphine—Vomiting—Betamethasone—psoriasis	0.00087	0.000903	CcSEcCtD
Apomorphine—Vomiting—Dexamethasone—psoriasis	0.00087	0.000903	CcSEcCtD
Apomorphine—Fatigue—Methotrexate—psoriasis	0.000859	0.000891	CcSEcCtD
Apomorphine—Headache—Dexamethasone—psoriasis	0.000857	0.00089	CcSEcCtD
Apomorphine—Headache—Betamethasone—psoriasis	0.000857	0.00089	CcSEcCtD
Apomorphine—Asthenia—Prednisone—psoriasis	0.000855	0.000887	CcSEcCtD
Apomorphine—Pruritus—Prednisone—psoriasis	0.000843	0.000875	CcSEcCtD
Apomorphine—Feeling abnormal—Methotrexate—psoriasis	0.000821	0.000852	CcSEcCtD
Apomorphine—Diarrhoea—Prednisone—psoriasis	0.000816	0.000846	CcSEcCtD
Apomorphine—Nausea—Dexamethasone—psoriasis	0.000813	0.000844	CcSEcCtD
Apomorphine—Nausea—Betamethasone—psoriasis	0.000813	0.000844	CcSEcCtD
Apomorphine—Dizziness—Prednisone—psoriasis	0.000788	0.000818	CcSEcCtD
Apomorphine—Vomiting—Prednisone—psoriasis	0.000758	0.000786	CcSEcCtD
Apomorphine—Headache—Prednisone—psoriasis	0.000747	0.000775	CcSEcCtD
Apomorphine—Asthenia—Methotrexate—psoriasis	0.000715	0.000742	CcSEcCtD
Apomorphine—Nausea—Prednisone—psoriasis	0.000708	0.000735	CcSEcCtD
Apomorphine—Pruritus—Methotrexate—psoriasis	0.000705	0.000731	CcSEcCtD
Apomorphine—Diarrhoea—Methotrexate—psoriasis	0.000682	0.000707	CcSEcCtD
Apomorphine—Dizziness—Methotrexate—psoriasis	0.000659	0.000683	CcSEcCtD
Apomorphine—Vomiting—Methotrexate—psoriasis	0.000633	0.000657	CcSEcCtD
Apomorphine—Headache—Methotrexate—psoriasis	0.000624	0.000647	CcSEcCtD
Apomorphine—Nausea—Methotrexate—psoriasis	0.000592	0.000614	CcSEcCtD
Apomorphine—HTR2B—Signaling by GPCR—TYK2—psoriasis	1.94e-05	0.000534	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—SOCS1—psoriasis	1.91e-05	0.000528	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—SOCS1—psoriasis	1.89e-05	0.000521	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—SOCS1—psoriasis	1.89e-05	0.000521	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—VEGFA—psoriasis	1.87e-05	0.000517	CbGpPWpGaD
Apomorphine—HTR2B—GPCR downstream signaling—CXCL8—psoriasis	1.86e-05	0.000512	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—CXCL8—psoriasis	1.83e-05	0.000506	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—TYK2—psoriasis	1.83e-05	0.000504	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—CAT—psoriasis	1.81e-05	0.000499	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—TYK2—psoriasis	1.8e-05	0.000497	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—TYK2—psoriasis	1.8e-05	0.000497	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—CXCL8—psoriasis	1.79e-05	0.000495	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—CXCL8—psoriasis	1.77e-05	0.000487	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—CXCL8—psoriasis	1.75e-05	0.000483	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—CXCL8—psoriasis	1.73e-05	0.000477	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—CXCL8—psoriasis	1.73e-05	0.000477	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—SOCS1—psoriasis	1.71e-05	0.000471	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—CXCL8—psoriasis	1.69e-05	0.000465	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—SOCS1—psoriasis	1.65e-05	0.000454	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—SOCS1—psoriasis	1.64e-05	0.000452	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—LEP—psoriasis	1.63e-05	0.00045	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—APOE—psoriasis	1.63e-05	0.00045	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—TYK2—psoriasis	1.63e-05	0.000449	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TYK2—psoriasis	1.62e-05	0.000448	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—LEP—psoriasis	1.6e-05	0.00044	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—APOE—psoriasis	1.6e-05	0.00044	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SOCS1—psoriasis	1.59e-05	0.00044	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—CXCL8—psoriasis	1.59e-05	0.000439	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.57e-05	0.000433	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—LEP—psoriasis	1.57e-05	0.000433	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—APOE—psoriasis	1.57e-05	0.000433	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—CXCL8—psoriasis	1.57e-05	0.000433	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—CXCL8—psoriasis	1.57e-05	0.000433	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SOCS1—psoriasis	1.57e-05	0.000433	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.56e-05	0.000431	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	1.56e-05	0.00043	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—VEGFA—psoriasis	1.52e-05	0.00042	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—TYK2—psoriasis	1.52e-05	0.000419	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—NFKBIA—psoriasis	1.52e-05	0.000419	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—TP53—psoriasis	1.51e-05	0.000418	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.51e-05	0.000415	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—LEP—psoriasis	1.5e-05	0.000414	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—APOE—psoriasis	1.5e-05	0.000414	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.5e-05	0.000413	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—TYK2—psoriasis	1.5e-05	0.000413	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—NFKBIA—psoriasis	1.49e-05	0.00041	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—CAT—psoriasis	1.47e-05	0.000406	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—NFKBIA—psoriasis	1.46e-05	0.000404	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	1.46e-05	0.000402	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SOCS1—psoriasis	1.45e-05	0.000399	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	1.43e-05	0.000396	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.42e-05	0.000393	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	1.42e-05	0.000391	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—TP53—psoriasis	1.41e-05	0.00039	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CXCL8—psoriasis	1.41e-05	0.00039	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—APOE—psoriasis	1.41e-05	0.00039	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—LEP—psoriasis	1.41e-05	0.00039	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—APOE—psoriasis	1.41e-05	0.000388	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—NFKBIA—psoriasis	1.4e-05	0.000385	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—APOE—psoriasis	1.39e-05	0.000385	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—LEP—psoriasis	1.39e-05	0.000385	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—APOE—psoriasis	1.39e-05	0.000385	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—LEP—psoriasis	1.39e-05	0.000385	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—TYK2—psoriasis	1.38e-05	0.00038	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.37e-05	0.000377	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.36e-05	0.000375	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.36e-05	0.000374	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—IL6—psoriasis	1.34e-05	0.000371	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	1.32e-05	0.000365	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.32e-05	0.000365	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—NFKBIA—psoriasis	1.32e-05	0.000363	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—JUN—psoriasis	1.31e-05	0.000363	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	1.3e-05	0.000359	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.3e-05	0.000359	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—NFKBIA—psoriasis	1.3e-05	0.000359	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	1.3e-05	0.000359	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.29e-05	0.000357	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—NFKB1—psoriasis	1.26e-05	0.000349	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—APOE—psoriasis	1.26e-05	0.000347	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—LEP—psoriasis	1.26e-05	0.000347	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TYK2—psoriasis	1.24e-05	0.000343	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.23e-05	0.000341	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PPARG—psoriasis	1.22e-05	0.000338	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TYK2—psoriasis	1.22e-05	0.000336	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—LEP—psoriasis	1.22e-05	0.000335	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—APOE—psoriasis	1.22e-05	0.000335	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—LEP—psoriasis	1.21e-05	0.000334	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—APOE—psoriasis	1.21e-05	0.000334	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.2e-05	0.000331	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TYK2—psoriasis	1.2e-05	0.000331	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.18e-05	0.000327	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.18e-05	0.000326	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—LEP—psoriasis	1.18e-05	0.000325	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—APOE—psoriasis	1.18e-05	0.000325	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	1.17e-05	0.000324	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—LEP—psoriasis	1.16e-05	0.000319	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—APOE—psoriasis	1.16e-05	0.000319	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—TP53—psoriasis	1.15e-05	0.000317	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—VEGFA—psoriasis	1.15e-05	0.000317	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TYK2—psoriasis	1.14e-05	0.000316	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—APOE—psoriasis	1.14e-05	0.000315	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—STAT3—psoriasis	1.14e-05	0.000314	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.13e-05	0.000312	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.13e-05	0.000311	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	1.1e-05	0.000302	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CXCL8—psoriasis	1.08e-05	0.000299	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TYK2—psoriasis	1.08e-05	0.000298	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	1.08e-05	0.000298	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	1.07e-05	0.000297	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—LEP—psoriasis	1.07e-05	0.000294	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—APOE—psoriasis	1.07e-05	0.000294	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TYK2—psoriasis	1.06e-05	0.000294	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TYK2—psoriasis	1.06e-05	0.000294	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CXCL8—psoriasis	1.06e-05	0.000293	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—LEP—psoriasis	1.05e-05	0.00029	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—APOE—psoriasis	1.05e-05	0.00029	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CXCL8—psoriasis	1.04e-05	0.000288	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—IL6—psoriasis	1.03e-05	0.000284	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—IL6—psoriasis	1.01e-05	0.000278	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—JUN—psoriasis	1.01e-05	0.000278	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CXCL8—psoriasis	9.96e-06	0.000275	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PPARG—psoriasis	9.95e-06	0.000275	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NFKBIA—psoriasis	9.94e-06	0.000274	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—IL6—psoriasis	9.92e-06	0.000274	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—JUN—psoriasis	9.85e-06	0.000272	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	9.78e-06	0.00027	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—JUN—psoriasis	9.7e-06	0.000268	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—NFKB1—psoriasis	9.69e-06	0.000267	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TYK2—psoriasis	9.61e-06	0.000265	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—LEP—psoriasis	9.55e-06	0.000264	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—APOE—psoriasis	9.55e-06	0.000264	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—NFKB1—psoriasis	9.49e-06	0.000262	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—IL6—psoriasis	9.47e-06	0.000261	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CXCL8—psoriasis	9.39e-06	0.000259	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—NFKB1—psoriasis	9.33e-06	0.000258	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TYK2—psoriasis	9.27e-06	0.000256	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CXCL8—psoriasis	9.27e-06	0.000256	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CXCL8—psoriasis	9.27e-06	0.000256	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—JUN—psoriasis	9.26e-06	0.000255	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TYK2—psoriasis	9.23e-06	0.000255	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TYK2—psoriasis	8.97e-06	0.000248	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL6—psoriasis	8.93e-06	0.000246	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—NFKB1—psoriasis	8.91e-06	0.000246	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	8.9e-06	0.000246	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TYK2—psoriasis	8.83e-06	0.000244	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL6—psoriasis	8.81e-06	0.000243	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL6—psoriasis	8.81e-06	0.000243	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—VEGFA—psoriasis	8.79e-06	0.000243	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—JUN—psoriasis	8.73e-06	0.000241	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—STAT3—psoriasis	8.71e-06	0.00024	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TP53—psoriasis	8.67e-06	0.000239	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—JUN—psoriasis	8.61e-06	0.000238	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—JUN—psoriasis	8.61e-06	0.000238	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—VEGFA—psoriasis	8.61e-06	0.000238	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—STAT3—psoriasis	8.52e-06	0.000235	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—VEGFA—psoriasis	8.47e-06	0.000234	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—NFKB1—psoriasis	8.4e-06	0.000232	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—STAT3—psoriasis	8.39e-06	0.000232	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	8.36e-06	0.000231	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—NFKB1—psoriasis	8.29e-06	0.000229	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—NFKB1—psoriasis	8.29e-06	0.000229	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TYK2—psoriasis	8.14e-06	0.000225	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—psoriasis	8.09e-06	0.000223	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CXCL8—psoriasis	8.07e-06	0.000223	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CXCL8—psoriasis	8.03e-06	0.000222	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TYK2—psoriasis	8.01e-06	0.000221	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—STAT3—psoriasis	8.01e-06	0.000221	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—psoriasis	7.95e-06	0.00022	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—psoriasis	7.94e-06	0.000219	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CXCL8—psoriasis	7.81e-06	0.000216	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—JUN—psoriasis	7.78e-06	0.000215	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	7.69e-06	0.000212	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—psoriasis	7.68e-06	0.000212	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—psoriasis	7.64e-06	0.000211	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—psoriasis	7.63e-06	0.00021	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—STAT3—psoriasis	7.55e-06	0.000208	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—psoriasis	7.53e-06	0.000208	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—psoriasis	7.53e-06	0.000208	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—JUN—psoriasis	7.51e-06	0.000207	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	7.49e-06	0.000207	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—JUN—psoriasis	7.47e-06	0.000206	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—STAT3—psoriasis	7.45e-06	0.000206	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—STAT3—psoriasis	7.45e-06	0.000206	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—psoriasis	7.43e-06	0.000205	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—psoriasis	7.31e-06	0.000202	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TYK2—psoriasis	7.29e-06	0.000201	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—JUN—psoriasis	7.26e-06	0.0002	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NFKB1—psoriasis	7.23e-06	0.000199	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NFKB1—psoriasis	7.19e-06	0.000198	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—JUN—psoriasis	7.15e-06	0.000197	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CXCL8—psoriasis	7.09e-06	0.000196	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NFKB1—psoriasis	6.99e-06	0.000193	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CXCL8—psoriasis	6.98e-06	0.000193	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	6.88e-06	0.00019	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	6.79e-06	0.000188	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—psoriasis	6.74e-06	0.000186	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—STAT3—psoriasis	6.73e-06	0.000186	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—psoriasis	6.64e-06	0.000183	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—psoriasis	6.63e-06	0.000183	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—JUN—psoriasis	6.59e-06	0.000182	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—psoriasis	6.56e-06	0.000181	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—psoriasis	6.52e-06	0.00018	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—psoriasis	6.51e-06	0.00018	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—STAT3—psoriasis	6.49e-06	0.000179	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—JUN—psoriasis	6.49e-06	0.000179	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—STAT3—psoriasis	6.46e-06	0.000178	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—psoriasis	6.4e-06	0.000177	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	6.35e-06	0.000175	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—psoriasis	6.35e-06	0.000175	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NFKB1—psoriasis	6.34e-06	0.000175	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—STAT3—psoriasis	6.28e-06	0.000173	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	6.25e-06	0.000172	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NFKB1—psoriasis	6.24e-06	0.000172	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—STAT3—psoriasis	6.18e-06	0.000171	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—psoriasis	6.11e-06	0.000169	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—psoriasis	6.08e-06	0.000168	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—psoriasis	6.03e-06	0.000167	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—psoriasis	5.95e-06	0.000164	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—JUN—psoriasis	5.9e-06	0.000163	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—psoriasis	5.86e-06	0.000162	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—psoriasis	5.76e-06	0.000159	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—psoriasis	5.76e-06	0.000159	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—STAT3—psoriasis	5.7e-06	0.000157	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—psoriasis	5.69e-06	0.000157	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—psoriasis	5.69e-06	0.000157	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	5.68e-06	0.000157	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—psoriasis	5.67e-06	0.000156	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—STAT3—psoriasis	5.61e-06	0.000155	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—psoriasis	5.59e-06	0.000154	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—psoriasis	5.27e-06	0.000146	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—psoriasis	5.2e-06	0.000144	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—psoriasis	5.2e-06	0.000144	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	5.15e-06	0.000142	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—psoriasis	5.13e-06	0.000142	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—STAT3—psoriasis	5.1e-06	0.000141	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—psoriasis	4.96e-06	0.000137	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—psoriasis	4.93e-06	0.000136	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—psoriasis	4.8e-06	0.000132	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—psoriasis	4.72e-06	0.00013	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—psoriasis	4.7e-06	0.00013	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—psoriasis	4.54e-06	0.000125	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—psoriasis	4.51e-06	0.000125	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—psoriasis	4.39e-06	0.000121	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—psoriasis	4.35e-06	0.00012	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—psoriasis	4.32e-06	0.000119	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—psoriasis	4.28e-06	0.000118	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—psoriasis	3.98e-06	0.00011	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—psoriasis	3.92e-06	0.000108	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—psoriasis	3.89e-06	0.000107	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—psoriasis	3.57e-06	9.84e-05	CbGpPWpGaD
